Case Report
Copyright ©The Author(s) 2021.
World J Cardiol. Jan 26, 2021; 13(1): 28-37
Published online Jan 26, 2021. doi: 10.4330/wjc.v13.i1.28
Table 1 Strategies to mitigate selected modifiable risk factors associated with anthracycline-induced cardiotoxicity
Risk factor
Risk-reduction strategy
HypertensionLifestyle modification and pharmacologic control
DiabetesLifestyle modification and pharmacologic control
DyslipidemiaLifestyle modification and pharmacologic control
SmokingSmoking cessation
Coronary artery diseaseLifestyle modification and pharmacologic control
ObesityLifestyle modification and weight management